C12N 2510/02
Cells for production
C12N2510/02 (Cells for production) appears on 841 US grants and 1,437 published applications in this corpus.
Search patents in C12N- Granted patents
- 841
- Published applications
- 1,437
- Assignees
- 658
- Inventors
- 2,881
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 16 | 0 |
| 2000 | 12 | 0 |
| 2001 | 23 | 13 |
| 2002 | 18 | 40 |
| 2003 | 21 | 57 |
| 2004 | 12 | 38 |
| 2005 | 19 | 48 |
| 2006 | 18 | 48 |
| 2007 | 22 | 51 |
| 2008 | 16 | 42 |
| 2009 | 23 | 45 |
| 2010 | 22 | 51 |
| 2011 | 27 | 46 |
| 2012 | 34 | 53 |
| 2013 | 32 | 31 |
| 2014 | 33 | 42 |
| 2015 | 40 | 44 |
| 2016 | 37 | 64 |
| 2017 | 32 | 96 |
| 2018 | 27 | 59 |
| 2019 | 40 | 67 |
| 2020 | 48 | 88 |
| 2021 | 46 | 65 |
| 2022 | 38 | 91 |
| 2023 | 39 | 67 |
| 2024 | 37 | 69 |
| 2025 | 38 | 79 |
| 2026 | 31 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- circCDK13-enriched engineered small extracellular vesicle (E-sEV), and preparation method and use thereof22 Sep 2026US 12,740,945 B2Chinese Pla General Hospital
- Cellulose constructs based on gas vesicles and bacterial cellulose15 Sep 2026US 12,735,674 B1
- Engineered exosome for treating hypertrophic scar (HTS), and preparation method and use thereof15 Sep 2026US 12,735,708 B2Chinese Pla General Hospital
- Production of MHC II/CII complexes1 Sep 2026US 12,721,884 B2
- Taurine supplemented cell culture medium and methods of use25 Aug 2026US 12,716,051 B2Regeneron Pharmaceuticals, Inc.
- Genetically engineered cd4 t-cells for in situ synthesis of proteins8 Oct 2026US 2026/0308515 A1SRI International
- Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof8 Oct 2026US 2026/0308529 A1Imagine Pharma LLC
- Method of producing iridoids1 Oct 2026US 2026/0297601 A1Nicoventures Trading Limited
- Photobiological hydrogen production method based on cell engineering1 Oct 2026US 2026/0297629 A1Industry-Academic Cooperation Foundation, Yonsei University
- Method for expansion culture of insect cells24 Sep 2026US 2026/0286291 A1Sumitomo Chemical Company, Limited
Most cited
By later US patents
- Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products448US 6,083,523 ABrown University · 2000
- Production of a multimeric protein by cell fusion method411US 5,916,771 AAbgenix, Inc. · 1999
- Cardiac muscle regeneration using mesenchymal stem cells281US 6,387,369 B1Osiris Therapeutics, Inc. · 2002
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Protein production and protein delivery172US 5,641,670 ATranskaryotic Therapies, Inc. · 1997